Form 13-F position report

ORAMED PHARM INC

Reported by SG Americas Securities LLC

ORMP CUSIP 68403P203 Manager CIK 0001313360

First reported at 23,446 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q1 2025
Shares 23,446 Quarter-end amount reported
Reported value $50,000 Fair value at quarter end
Consecutive quarters held 1 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 298000
2021-12-31 123000
2022-03-31 0
2022-06-30 213000
2022-09-30 67000
2022-12-31 125000
2023-03-31 0
2025-03-31 50000
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for ORAMED PHARM INC held by SG Americas Securities LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -23,446 (-100.0%) 0 $0 2025-08-08
Q1 2025 New 23,446 +23,446 (0.0%) < 0.01% $50,000 2025-04-15
Q1 2023 Reduced 0 -10,370 (-100.0%) 0 $0 2023-04-28
Q4 2022 Unchanged 10,370 0 (0.0%) < 0.01% $125,000 2023-02-02
Q3 2022 Reduced 10,370 -36,162 (-77.7%) < 0.01% $67,000 2022-10-31
Q2 2022 New 46,532 +46,532 (0.0%) < 0.01% $213,000 2022-07-29
Q1 2022 Reduced 0 -8,631 (-100.0%) 0 $0 2022-04-29
Q4 2021 Reduced 8,631 -4,910 (-36.3%) < 0.01% $123,000 2022-02-07
Q3 2021 New 13,541 +13,541 (0.0%) < 0.01% $298,000 2021-11-01

Who else reported the position

60 managers reported ORAMED PHARM INC for Q1 2025.

Managers reporting ORAMED PHARM INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BML Capital Management LLC Added 3,020,748 +376,841 5.23% $6,464,401 9 qtrs
Murchinson Ltd Added 1,751,759 +800 0.2% $3,748,764 6 qtrs
BOOTHBAY FUND MANAGEMENT LLC Added 845,488 +300 0.05% $1,809,344 6 qtrs
Peapod Lane Capital LLC Added 252,224 +24,985 0.61% $539,759 2 qtrs
Rathbones Group Plc Reduced 236,803 -53,000 < 0.01% $506,758 7 qtrs
TWO SIGMA ADVISERS LP Reduced 213,000 -28,400 < 0.01% $455,820 14 qtrs
Bank of America Corporation Reduced 163,695 -3,958 < 0.01% $350,307 35 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 142,500 -9,308 < 0.01% $304,950 9 qtrs
DIMENSIONAL FUND ADVISORS LP Added 141,081 +22,086 < 0.01% $301,913 7 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Added 100,196 +9,169 < 0.01% $214,419 17 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
April 15, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
23,446
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.